OTC Markets EXMKT - Delayed Quote USD
Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF)
0.0000
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT
Breakdown
TTM
3/31/2022
3/31/2021
Total Revenue
182,880,000
179,060,000
188,218,000
Cost of Revenue
195,694,000
175,094,000
166,973,000
Gross Profit
-12,813,000
3,965,000
21,245,000
Operating Expense
153,140,000
114,015,000
21,136,000
Operating Income
-165,953,000
-110,050,000
109,000
Net Non Operating Interest Income Expense
975,000
2,005,000
529,000
Pretax Income
-164,994,000
-107,842,000
1,068,000
Tax Provision
-3,749,000
-2,190,000
5,342,000
Net Income Common Stockholders
-160,439,000
-104,984,000
-4,179,000
Diluted NI Available to Com Stockholders
-160,439,000
-104,984,000
-4,179,000
Basic EPS
-160.44B
-104.98B
-65.17
Diluted EPS
-160.44B
-104.98B
-65.17
Basic Average Shares
0.0010
0.0010
64,126.0020
Diluted Average Shares
0.0010
0.0010
64,126.0020
Total Operating Income as Reported
-165,956,000
-110,051,000
107,000
Total Expenses
348,834,000
289,109,000
188,109,000
Net Income from Continuing & Discontinued Operation
-160,439,000
-104,984,000
-4,179,000
Normalized Income
-160,439,000
-104,984,000
-4,179,000
Interest Income
3,283,000
3,133,000
1,330,000
Interest Expense
2,308,000
1,128,000
801,000
Net Interest Income
975,000
2,005,000
529,000
EBIT
-162,686,000
-106,714,000
1,869,000
EBITDA
-152,351,000
-94,061,000
15,086,000
Reconciled Cost of Revenue
195,694,000
175,094,000
166,973,000
Reconciled Depreciation
10,335,000
12,653,000
13,217,000
Net Income from Continuing Operation Net Minority Interest
-160,439,000
-104,984,000
-4,179,000
Normalized EBITDA
-152,351,000
-94,061,000
15,086,000
Tax Rate for Calcs
0
0
0.0003
Tax Effect of Unusual Items
0
0
0
3/31/2021 - 5/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade